• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYL

CATALYST METALS LIMITED

7.69% ! $7.00
Market Cap $1.693B  !
Metals & Mining Industrial Metals & Minerals
Add to My Watchlist

Catalyst Metals (CYL) is an Australian gold mining and exploration company with dominant... Catalyst Metals (CYL) is an Australian gold mining and exploration company with dominant positions in three highly endowed gold belts in Australia. In WA, the Company has recently consolidated the Plutonic-Marymia belt and is implementing strategies and a new mine plan to increase gold production to over 100,000oz pa. In Tasmania, the Company owns and operates the Henty Gold Mine, with a renewed exploration focus and equipment overhaul underway to extend the life of the operation. The Company also owns the northerly extensions of the Bendigo Goldfields, with high grade Bendigo-style mineral resources defined at the Four Eagles Project. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYL
CYL chart
2
14:15 84 46K
14:15 Last post  wave4 Comments Created with Sketch.  84  Views Created with Sketch.  46K 
CYL
Presentations, Media and Research
5 6 7
11:16 360 127K
11:16 Last post  Greatone Comments Created with Sketch.  360  Views Created with Sketch.  127K 
CYL
Ann: CFO Update 		11/12/25 16 5.2K
TRENDING NEWS

An hour ago silver hit a new all time high... here are the 8 ASX silver stocks we are invested in.

Download here right-arrow Created with Sketch.
NEWS
17 Dec 2025
11/12/25 Last post  litiselite Comments Created with Sketch.  16  Views Created with Sketch.  5.2K 
CYL
Ann: Change of Director's Interest Notice 		04/12/25 7 1.8K
04/12/25 Last post  Agil Comments Created with Sketch.  7  Views Created with Sketch.  1.8K 
CYL
Ann: Change in substantial holding 		29/11/25 13 2.8K
29/11/25 Last post  Furpo2 Comments Created with Sketch.  13  Views Created with Sketch.  2.8K 
CYL
Ann: 100% ownership over critical piece of Plutonic Belt secured 		20/11/25 25 6.7K
20/11/25 Last post  kori Comments Created with Sketch.  25  Views Created with Sketch.  6.7K 
CYL
Ann: Section 708A notice 		18/11/25 0 224
18/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  224 
CYL
Ann: Application for quotation of securities - CYL 		18/11/25 0 215
18/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  215 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice
03 Dec 19:30
 
CFO Update
02 Dec 09:15
 
Change in substantial holding
27 Nov 18:24
 
Section 708A notice
18 Nov 20:06
 
Application for quotation of securities - CYL
18 Nov 20:00
 
Proposed issue of securities - CYL
17 Nov 09:02
 
View More arrow Created with Sketch.

Featured News

NEWS Exclusive Pre-IPO & Investment Opportunities in North America, Australia, and the UK
right-arrow Created with Sketch.
NEWS 'Best for value': Rio Tinto is quickly downsizing its once-grand Aussie lithium plans
right-arrow Created with Sketch.
NEWS DealRoom is expanding: Your global gateway to capital-raising investments
right-arrow Created with Sketch.
OVT Ovanti Locks in Strategic U.S. Payments Partner
right-arrow Created with Sketch.
NEWS Listen to the HotCopper Wire Podcast here
right-arrow Created with Sketch.
CMP MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$7.00 		Change
0.500(7.69%) 		Mkt cap ! $1.693B
Open High Low Volume
$6.49 $7.05 $6.33 997.3K

Buyers (Bids)

Vol. Price($)
100 $6.99
 

Sellers (Offers)

Price($) Vol.
$7.03 3111
Last trade - 16.25pm 17/12/2025 (20 minute delay) ?
CYL (ASX) Chart

Top Stories

Inside Racura Oncology: Strategy, clinical milestones, and the year ahead

It's been a huge year for Racura Oncology, and CY26 only promises to get bigger as the biotech developer leaves behind its "Race" name.
MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big breakthrough in imaging tech.
How EVR's 99% antimony concentrate sets up Los Lirios drilling EVR chief executive Mike Brown joins The Market Link to talk all the latest developments unfolding at Los Lirios heading into CY26.
Listen: HotCopper Wire CY25 Wrapped – Looking back at Invictus, Kaili, DRO, and more In the first half of the HotCopper Wire@s CY25 end-of-year special, Isaac McIntyre and Jonathon Davidson look back over the year that was through the half-dozen biggest stories covered on the podcast and HotCopper.There are a half-dozen that truly stood out, including: DroneShield Invictus En...
DealRoom is expanding: Your global gateway to capital-raising investments DealRoom is expanding into the U.K., in a brand-new chapter in cross-border deal flow to connect companies and investors across Australia.

Featured News

NEWS DealRoom is expanding: Your global gateway to capital-raising investments
right-arrow Created with Sketch.
NEWS 'Best for value': Rio Tinto is quickly downsizing its once-grand Aussie lithium plans
right-arrow Created with Sketch.
NEWS HotCopper Highlights, Week 50: 4DX above $2/sh, Nanoveu, Ovanti & more
right-arrow Created with Sketch.
CMP MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY
right-arrow Created with Sketch.
OVT Ovanti Locks in Strategic U.S. Payments Partner
right-arrow Created with Sketch.
NEWS Listen to the HotCopper Wire Podcast here
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.